These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22348399)

  • 1. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
    von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
    BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
    Benton SC; Butler P; Allen K; Chesters M; Rickard S; Stanley S; Roope R; Vulkan D; Duffy SW
    Br J Cancer; 2017 Jun; 116(12):1551-1557. PubMed ID: 28524157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
    Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
    Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
    Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
    Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
    Damery S; Clifford S; Wilson S
    BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
    Raine R; Duffy SW; Wardle J; Solmi F; Morris S; Howe R; Kralj-Hans I; Snowball J; Counsell N; Moss S; Hackshaw A; von Wagner C; Vart G; McGregor LM; Smith SG; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Atkin W
    Br J Cancer; 2016 Feb; 114(3):321-6. PubMed ID: 26742011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).
    Sali L; Grazzini G; Carozzi F; Castiglione G; Falchini M; Mallardi B; Mantellini P; Ventura L; Regge D; Zappa M; Mascalchi M; Milani S
    Trials; 2013 Mar; 14():74. PubMed ID: 23497601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
    Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
    Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
    Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
    BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using primary care-based paper and telephone interventions to increase uptake of bowel scope screening in Yorkshire: a protocol of a randomised controlled trial.
    McGregor LM; Kerrison RS; Green T; Macleod U; Hughes M; Gibbins M; Morris S; Rees C; von Wagner C
    BMJ Open; 2018 Jul; 8(7):e024616. PubMed ID: 30056395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.
    Regge D; Iussich G; Senore C; Correale L; Hassan C; Bert A; Montemezzi S; Segnan N
    Trials; 2014 Mar; 15():97. PubMed ID: 24678896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effectiveness and cost-effectiveness of text-message reminders and telephone patient navigation to improve the uptake of faecal immunochemical test screening among non-responders in London: a randomised controlled trial protocol.
    Duffy T; Gil N; Siddique B; Duffy S; Prentice A; Marshall S; Djedovic NK; Lewis M; Ruwende J; von Wagner C; Kerrison R
    BMJ Open; 2024 Jun; 14(6):e079482. PubMed ID: 38909999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
    Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
    Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient.
    Koo JH; You MY; Liu K; Athureliya MD; Tang CW; Redmond DM; Connor SJ; Leong RW
    J Gastroenterol Hepatol; 2012 Feb; 27(2):390-6. PubMed ID: 21793910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population.
    Kaushal A; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Duffy S; von Wagner C
    Prev Med; 2020 Dec; 141():106268. PubMed ID: 33022321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study.
    Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Perez D; Travaglia J
    BMC Fam Pract; 2017 Mar; 18(1):36. PubMed ID: 28298185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.